EP
EBS icon

Essential Partners’s Emergent Biosolutions EBS Stock Holding History

Essential Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$832 Sell
126
-283
-69% -$1.86K ﹤0.01% 2251
2026
Q2 		$3.43K Sell
409
-618
-60% -$5.17K ﹤0.01% 1723
2026
Q1 		$8.52K Buy
1,027
+90
+10% +$932 ﹤0.01% 1331
2025
Q4 		$11.6K Buy
937
+195
+26% +$2.09K ﹤0.01% 1112
2025
Q3 		$6.54K Buy
+742
New +$5.77K ﹤0.01% 1324

Other funds holding EBS

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Essential Partners's EBS Position: Q3 2026 in Review

Essential Partners reduced its Emergent Biosolutions (EBS) stake by 69% in Q3 2026, selling an estimated $1.86K and leaving 126 shares worth $832. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Essential Partners first reported a position in EBS in Q3 2025 and has held it in 5 quarters since. The position peaked at $11.6K in Q4 2025. 7 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Essential Partners held 126 shares of Emergent Biosolutions worth $832 as of Q3 2026.
  • Essential Partners sold 283 Emergent Biosolutions shares in Q3 2026, an estimated $1.86K.
  • Emergent Biosolutions made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2251 holding.
  • Essential Partners first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 5 quarters since.
  • Essential Partners's Emergent Biosolutions position peaked at $11.6K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.